eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
15.50
+0.19 (1.24%)
Nov 28, 2025, 1:00 PM EST - Market closed

eXoZymes Statistics

Total Valuation

eXoZymes has a market cap or net worth of $133.11 million. The enterprise value is $129.33 million.

Market Cap133.11M
Enterprise Value 129.33M

Important Dates

The last earnings date was Thursday, November 13, 2025, after market close.

Earnings Date Nov 13, 2025
Ex-Dividend Date n/a

Share Statistics

eXoZymes has 8.39 million shares outstanding. The number of shares has increased by 30.51% in one year.

Current Share Class 8.39M
Shares Outstanding 8.39M
Shares Change (YoY) +30.51%
Shares Change (QoQ) +0.12%
Owned by Insiders (%) 25.58%
Owned by Institutions (%) 47.59%
Float 6.24M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 24.71
P/TBV Ratio 24.77
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.53, with a Debt / Equity ratio of 0.25.

Current Ratio 4.53
Quick Ratio 4.36
Debt / Equity 0.25
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -940.69% and return on invested capital (ROIC) is -125.71%.

Return on Equity (ROE) -940.69%
Return on Assets (ROA) -99.79%
Return on Invested Capital (ROIC) -125.71%
Return on Capital Employed (ROCE) -138.94%
Revenue Per Employee n/a
Profits Per Employee -$269,022
Employee Count31
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax -2,143
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +15.07% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +15.07%
50-Day Moving Average 13.96
200-Day Moving Average 12.94
Relative Strength Index (RSI) 57.64
Average Volume (20 Days) 2,688

Short Selling Information

The latest short interest is 13,458, so 0.16% of the outstanding shares have been sold short.

Short Interest 13,458
Short Previous Month 14,548
Short % of Shares Out 0.16%
Short % of Float 0.22%
Short Ratio (days to cover) 0.60

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -9.00M
Pretax Income -8.34M
Net Income -8.34M
EBITDA -8.72M
EBIT -9.00M
Earnings Per Share (EPS) -$1.02
Full Income Statement

Balance Sheet

The company has $5.10 million in cash and $1.32 million in debt, giving a net cash position of $3.78 million or $0.45 per share.

Cash & Cash Equivalents 5.10M
Total Debt 1.32M
Net Cash 3.78M
Net Cash Per Share $0.45
Equity (Book Value) 5.37M
Book Value Per Share 0.64
Working Capital 4.37M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$10.24 million and capital expenditures -$305,335, giving a free cash flow of -$10.54 million.

Operating Cash Flow -10.24M
Capital Expenditures -305,335
Free Cash Flow -10.54M
FCF Per Share -$1.26
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

eXoZymes does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -30.51%
Shareholder Yield -30.51%
Earnings Yield -6.27%
FCF Yield -7.92%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1